These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 181189)

  • 1. The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration.
    Lomnitzer R; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1976 Apr; 24(1):42-8. PubMed ID: 181189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucocyte capillary migration: an adherence dependent phenomenon.
    Lomnitzer R; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1976 Aug; 25(2):303-10. PubMed ID: 182422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
    Kijlstra A; Broersma L
    Clin Exp Immunol; 1984 Feb; 55(2):459-64. PubMed ID: 6365377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
    Hahn T; Levin S; Handzel ZT
    Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro modulation of human leucocyte migration and migration inhibitory factor (LIF) activity by cyclic 3',5'-AMP and cyclic 3',5'-GMP.
    Bendtzen K; Palit J
    Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):78-80. PubMed ID: 190856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin.
    Rivkin I; Rosenblatt J; Becker EL
    J Immunol; 1975 Oct; 115(4):1126-34. PubMed ID: 170335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of theophylline on capillary tube leucocyte migration.
    Stevenson RD; Gray AC; Lucie NP
    Int Arch Allergy Appl Immunol; 1979; 59(2):155-61. PubMed ID: 221423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced effects of prostaglandin E1 and dibutyryl cyclic AMP upon human lymphocytes in the presence of cortisol.
    Mendelsohn J; Multer MM; Boone RF
    J Clin Invest; 1973 Sep; 52(9):2129-37. PubMed ID: 4353772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin effect on lymphokine production in multiple sclerosis.
    Willoughby EW; Dupont B; Good RA
    Ann Neurol; 1979 Apr; 5(4):391-3. PubMed ID: 375809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cAMP and related compounds on newt epidermal cell migration both in vivo and in vitro.
    Dunlap MK; Donaldson DJ
    J Exp Zool; 1980 Apr; 212(1):13-9. PubMed ID: 6251154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E2.
    Oppenheimer-Marks N; Kavanaugh AF; Lipsky PE
    J Immunol; 1994 Jun; 152(12):5703-13. PubMed ID: 8207201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of elevated levels of adenosine-3':5' cyclic monophosphate on phagocytosis: effects on macrophage-Trypanosoma cruzi interaction.
    Wirth JJ; Kierszenbaum F
    J Immunol; 1982 Dec; 129(6):2759-62. PubMed ID: 6292299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human polymorphonuclear leucocyte migration inhibitory factor. Evidence for antigen dependency.
    Weisbart RH; Isaacson J; Bluestone R; Goldberg LS
    Immunology; 1975 Aug; 29(2):223-30. PubMed ID: 50998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of anesthesia and surgical trauma on the immune response of pediatric patients].
    Jirillo E; Fransvea P; De Santis A; Dolce M; Monno R; Munno L; Pasquetto N
    G Batteriol Virol Immunol; 1977; 70(1-6):40-8. PubMed ID: 350684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents.
    Plaut M; Marone G; Gillespie E
    J Immunol; 1983 Dec; 131(6):2945-52. PubMed ID: 6315818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of PHA-activated MN-cell supernatants on polymorphonuclear leucocyte function.
    Lomnitzer R; Glover A; Rabson AR
    Clin Exp Immunol; 1977 Sep; 29(3):501-8. PubMed ID: 589867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones.
    Melmon KL; Bourne HR; Weinstein Y; Shearer GM; Kram J; Bauminger S
    J Clin Invest; 1974 Jan; 53(1):13-21. PubMed ID: 4357609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do protease inhibitors enhance leucocyte migration inhibition to the antigen PPD?
    Burden AC; Stacey R; Wood RF; Bell PR
    Immunology; 1978 Dec; 35(6):959-62. PubMed ID: 310809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.